🇺🇸 FDA
Patent

US 10588943

Glucokinase activator compositions for the treatment of diabetes

granted A61KA61K31/426A61K31/4985

Quick answer

US patent 10588943 (Glucokinase activator compositions for the treatment of diabetes) held by VTV THERAPEUTICS LLC expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/426, A61K31/4985, A61K38/22, A61K38/26